跳至主要内容
临床试验/ISRCTN71665562
ISRCTN71665562已完成未知

Ketogenic diets as an adjuvant therapy In glioblastoma: a randomised pilot study

niversity of Liverpool0 个研究点目标入组 12 人开始时间: 2017年3月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • From 31/08/2017:
  • 1. Age 16 years and over
  • 2. Patient at The Walton Centre NHS Foundation Trust
  • 3. Performance status =2 (S?rensen et al., 1993)
  • 4. Confirmed histological diagnosis of GB (WHO grade IV)
  • 5. Undergone surgical resection or biopsy within the last 4 months and will go onto receive/ is currently receiving/ has received oncological treatment
  • Before 31/08/2017:
  • 1. Age 16 years and over
  • 2. Patient at The Walton Centre NHS Foundation Trust
  • 3. Performance status =2 (S?rensen et al., 1993)
  • 4. Confirmed histological diagnosis of GB (WHO grade IV)
  • 5. Undergone surgical resection and will go onto receive chemoradiotherapy

排除标准

  • From 31/08/2017:
  • 1. Having prior use of a ketogenic diet
  • 2. Kidney dysfunction
  • 3. Liver dysfunction
  • 4. Gall bladder dysfunction
  • 5. Metabolic disorder
  • 6. Eating disorder
  • 7. Diabetes (requiring medication)
  • 8. Body mass index (BMI) =18.5kg/m2
  • 9. Weight loss medications
  • 10. Currently pregnant or breastfeeding
  • 11. Performance status =3
  • Before 31/08/2017:
  • 1. Having prior use of a ketogenic diet
  • 2. Kidney dysfunction
  • 3. Liver dysfunction
  • 4. Gall bladder dysfunction
  • 5. Metabolic disorder
  • 6. Eating disorder
  • 7. Diabetes (requiring medication)
  • 8. Body mass index (BMI) =18.5kg/m2
  • 9. Weight loss medications
  • 10. Pregnancy
  • 11. Performance status =3

研究者

发起方
niversity of Liverpool

相似试验